COPD: open trials in Portugal

• NCT07555483

  A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

  Trial Treatment · Phase 3 · Grifols Therapeutics LLC

  GC2501 Study Site 450, Guimarães · GC2501 Study Site 451, Loures

  Registry updated 2026-10-26

• NCT06959095

  Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

  Trial Treatment · Phase 3 · GlaxoSmithKline

  Unidade Local De Saude De Almada-Seixal E.P.E., Almada · Unidade Local De Saude Da Guarda E.P.E., Guarda · Lusiadas S.A., Lisbon · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Hospital da Luz, S.A, Lisbon · Unidade Local De Saude De Loures-Odivelas EPE, Loures · Unidade Local De Saude De Matosinhos E.P.E., Senhora Da Hora · Hospor Hospitais Portugueses S.A., Setubal · Hospital da Luz Arrabida, S.A., Vila Nova de Gaia

  Registry updated 2026-10-05

• NCT06782724

  Psilocybin Therapy for Psychological Distress in Palliative Patients

  Trial Treatment · Phase 2 · University Medical Center Groningen

  Champalimaud Clinical Centre, Lisbon

  Registry updated 2026-05-08

• NCT06968273

  Analysis of Muscle Oxygen Saturation and Functional Variables During Physical Capacity Assessments in Patients With COPD

  Trial Treatment · University of Extremadura

  Unidade Local de Saúde do Alto Alentejo (ULSAALE), Hospitals of Portalegre and Elvas, Portugal, Portalegre

  Registry updated 2025-05-13

• NCT06732869

  Effectiveness of a Physical ACtivity Coaching Intervention Using E-Health for COPD Patients in Pulmonary Rehabilitation

  Trial Treatment · Instituto Politécnico de Leiria

  Center for Innovative Care and Health Technology (ciTechCare), Polytechnic of Leiria, Leiria

  Registry updated 2024-12-13

All COPD trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error